Read + Share
Amedeo Smart
Independent Medical Education
Dasgupta P, Ou A, Lin H, Gregory T, et al. The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab. J Neurooncol 2024 Feb 19. doi: 10.1007/s11060-023-04551.PMID: 38372903
Email
LinkedIn
Facebook
Twitter
Privacy Policy